Skip to content
healthcare.dev

REGADENOSON

NDC 16729-477, REGADENOSON, injection, solution, from Accord Healthcare Inc..

Product NDC
16729-477
Status
Listed
Labeler
Accord Healthcare Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213236
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-477 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
16729-477-31167290477315 mL in 1 SYRINGE, GLASS (16729-477-31)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=16729-477

Use it

Look up 16729-477 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-477 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-477. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.